DOI: https://doi.org/10.15674/0030-59872014251-57
Features of therapy for gonarthrosis in patients with decreased bone mineral density
Abstract
Keywords
Full Text:
PDF (Русский)References
European guidelines for the diagnosis and maintenance of osteoporosis in postmenopausal women / J. A. Kanis, N. Burlet, C. Cooper [et al.] / / Ukrainian Journal of Rheumatology. — 2008. — Vol. 4 (34). — P. 10-32.
Kovalenko V. N. Оsteoarthritis. Practical guidance / V. M. Kovalenko, A. P. Bortkiewicz. — 3rd ed. report, as amended. — Kyiv: Morion, 2010. — 608 p.
Kovalenko V. N. National textbook of rheumatology / V. M. Kovalenko, N. M. Shuba. — Kyiv: Morion, 2013. — 672 p.
Guidelines for diagnosis, prevention and treatment of systemic osteoporosis in women with postmenopausal / V. M. Kovalenko, V. V. Povoroznyuk, O. P. Bortkevych [et al.] // Ukrainian Journal of Rheumatology. — 2009. - № 3 (37). — P. 23-39.
Berenbaum F. Osteoarthritis, inflammation and obesity / F. Berenbaum, F. Eymard, X. Houard // Curr. Opin. Rheumatol. — 2013. — Vol. 25 (1). — P. 114–118.
Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study / S. K. Tat, J. P. Pelletier, J. Vergés [et al.] // Arthritis Res. Ther. — 2007. — Vol. 9 (6). — P. R117.
Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI / L. M. Wildi, J. P. Raynauld, J. Martel-Pelletier [et al.] // Ann. Rheum. Dis. — 2011. — Vol. 70 (6). — P. 982–989.
Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study / C. Ding, V. Parameswaran, R. U U dayan, G. Jones // J. Clin. Endocrinol. Metab. — 2008. — Vol. 93 (5). — P. 1952–1958.
Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metalloproteinases-3 and -13 in patients with flare-up of osteoarthritis / D. H. Manicourt, M. Bevilacqua, V. Righini [et al.] // Drugs. — 2005. — Vol. 6 (5). — P. 261–271.
Comparative efficacy and safety study of two chondroitin sulfate preparations from different origin (avian and bovine) in symptomatic osteoarthritis of the knee / P. Fardellone, M. Zaim, A. Saurel, E. Maheu // Open Rheumatol J. — 2013. — Vol. 7. — P. 1–12.
Findlay D. M. Vascular pathology and osteoarthritis / D. M. Findlay // Rheumatology. — 2007. — Vol. 46 (12). — P. 1763–1768.
Goldring M. B. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis / M. B. Goldring, S. R. Goldring // Ann. NY Acad. Sci. — 2010. — Vol. 1192. — P. 230–237.
Herman S. Molecular mechanisms of inflammatory bone damage: emerging targets for therapy / S. Herman, G. Kronke, G. Schett // Trends Mol. Med. — 2008. — Vol. 14 (6). — P. 245–253.
Immunomodulatory and anti-inflammatory effects of chondroitin sulphate / P. Du Souich, A. G. Garcia, J. Verges [et al.] // J. Cell. Mol. Med. — 2009. — Vol. 13 (8A). — P. 1451–1463.
Iovu M. Anti-inflammatory activity of chondroitin sul-fate / M. Iovu, G. Dumais, P. du Souich // Osteoarthritis Cartilage. — 2008. — Vol. 16. — P. S14–S8.4.
Kullich W. Effect of nimesulide on metalloproteinases and matrix degradation in osteoarthritis: a pilot clinical study / W. Kullich, F. Niksic, G. Klein // J. Clin. Pract.— 2002. — Vol. 28. — P. 24–30.
Mahjoub M. Why subchondral bone in osteoarthritis? The importance of the cartilage bone interface in osteoarthritis / M. Mahjoub, F. Berenbaum, X. Houard // Osteoporos Int. — 2012. — Vol. 23 (Suppl. 8). — P. 841–846.
Metabolic syndrome meets osteoarthritis / Q. Zhuo, W. Yang, J. Chen, Y. Wang // Nat. Rev. Rheumatol. — 2012. — Vol. 8 (12). — P. 729–737.
Copyright (c) 2014 Neonila Shuba, Tatiana Tarasenko

This work is licensed under a Creative Commons Attribution 4.0 International License.